Hepatitis C Screening in the Primary Care Setting

Hepatitis C Clinical Trial

Official title:

Prospective Cohort Study: Hepatitis C Screening in the Primary Care Setting

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03316313
• Other study ID #: BHS-1194
• Status: Completed
• Start date: June 2016
• Est. completion date: April 2017

Study information

• Verified date: October 2017
• Source: New York Institute of Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine whether patient education improves Hepatitis C screening in the primary care setting.

Description:

Hepatitis C is a chronic, asymptomatic infection that progresses to liver cirrhosis and cancer in the later stages if left untreated. The Centers for Disease Control (CDC) recommends a one-time screening for high risk birth cohort between the years 1945-1965. Prior studies have evaluated methods to improve screening for hepatitis c with focus on increasing awareness in health professionals. Targets included nursing staff and electronic medical records. This study targets providing patients with education resources to see if screening rates improve.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 503
• Est. completion date: April 2017
• Est. primary completion date: October 2016
• Gender: All
• Age group: 50 Years to 71 Years

Eligibility

Inclusion Criteria:

• All patients born between the years 1945 and 1965.

Exclusion Criteria:

• Patients who had already received a prior screening test for Hepatitis C before the office visit.

Related Conditions & MeSH terms

• Hepatitis
• Hepatitis A
• Hepatitis C

Intervention

Diagnostic Test:
• Hepatitis C Antibody
Patients who received a blood test to screen for the Hepatitis C virus.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
New York Institute of Technology

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Patients Screened for Hepatitis C	Change from baseline in number of patients from high-risk birth cohort screened for Hepatitis C during intervention period.	June 2016 to October 2016.